Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
BMJ Open ; 11(7): e047245, 2021 07 09.
Artigo em Inglês | MEDLINE | ID: mdl-34244267

RESUMO

OBJECTIVES: The Global Kidney Health Atlas (GKHA) is a multinational, cross-sectional survey designed to assess the current capacity for kidney care across all world regions. The 2017 GKHA involved 125 countries and identified significant gaps in oversight, funding and infrastructure to support care for patients with kidney disease, especially in lower-middle-income countries. Here, we report results from the survey for the second iteration of the GKHA conducted in 2018, which included specific questions about health financing and oversight of end-stage kidney disease (ESKD) care worldwide. SETTING: A cross-sectional global survey. PARTICIPANTS: Key stakeholders from 182 countries were invited to participate. Of those, stakeholders from 160 countries participated and were included. PRIMARY OUTCOMES: Primary outcomes included cost of kidney replacement therapy (KRT), funding for dialysis and transplantation, funding for conservative kidney management, extent of universal health coverage, out-of-pocket costs for KRT, within-country variability in ESKD care delivery and oversight systems for ESKD care. Outcomes were determined from a combination of desk research and input from key stakeholders in participating countries. RESULTS: 160 countries (covering 98% of the world's population) responded to the survey. Economic factors were identified as the top barrier to optimal ESKD care in 99 countries (64%). Full public funding for KRT was more common than for conservative kidney management (43% vs 28%). Among countries that provided at least some public coverage for KRT, 75% covered all citizens. Within-country variation in ESKD care delivery was reported in 40% of countries. Oversight of ESKD care was present in all high-income countries but was absent in 13% of low-income, 3% of lower-middle-income, and 10% of upper-middle-income countries. CONCLUSION: Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries.


Assuntos
Falência Renal Crônica , Diálise Renal , Estudos Transversais , Países em Desenvolvimento , Acessibilidade aos Serviços de Saúde , Humanos , Falência Renal Crônica/terapia
3.
Am J Kidney Dis ; 77(3): 326-335.e1, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-32800843

RESUMO

RATIONALE & OBJECTIVE: Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. OUTCOMES: Use, availability, accessibility, affordability, and quality of HD care. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2-9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. LIMITATIONS: A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. CONCLUSIONS: In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle-income countries.


Assuntos
Internacionalidade , Falência Renal Crônica/terapia , Padrões de Prática Médica , Diálise Renal , Derivação Arteriovenosa Cirúrgica , Custo Compartilhado de Seguro , Custos e Análise de Custo , Estudos Transversais , Países Desenvolvidos , Países em Desenvolvimento , Gastos em Saúde , Acessibilidade aos Serviços de Saúde , Humanos , Nefrologia , Medidas de Resultados Relatados pelo Paciente , Qualidade da Assistência à Saúde , Inquéritos e Questionários , Transporte de Pacientes
4.
Am J Kidney Dis ; 77(3): 315-325, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-32800844

RESUMO

RATIONALE & OBJECTIVE: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018. OUTCOMES: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. LIMITATIONS: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. CONCLUSIONS: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.


Assuntos
Acessibilidade aos Serviços de Saúde , Internacionalidade , Falência Renal Crônica/terapia , Diálise Peritoneal , Padrões de Prática Médica , Pessoal Administrativo , Custo Compartilhado de Seguro , Custos e Análise de Custo , Estudos Transversais , Atenção à Saúde , Países Desenvolvidos , Países em Desenvolvimento , Gastos em Saúde , Política de Saúde , Humanos , Nefrologistas , Nefrologia , Avaliação de Resultados em Cuidados de Saúde , Medidas de Resultados Relatados pelo Paciente , Médicos , Qualidade da Assistência à Saúde , Inquéritos e Questionários
5.
Nat Rev Nephrol ; 17(1): 15-32, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33188362

RESUMO

Globally, more than 5 million people die annually from lack of access to critical treatments for kidney disease - by 2040, chronic kidney disease is projected to be the fifth leading cause of death worldwide. Kidney diseases are particularly challenging to tackle because they are pathologically diverse and are often asymptomatic. As such, kidney disease is often diagnosed late, and the global burden of kidney disease continues to be underappreciated. When kidney disease is not detected and treated early, patient care requires specialized resources that drive up cost, place many people at risk of catastrophic health expenditure and pose high opportunity costs for health systems. Prevention of kidney disease is highly cost-effective but requires a multisectoral holistic approach. Each Sustainable Development Goal (SDG) has the potential to impact kidney disease risk or improve early diagnosis and treatment, and thus reduce the need for high-cost care. All countries have agreed to strive to achieve the SDGs, but progress is disjointed and uneven among and within countries. The six SDG Transformations framework can be used to examine SDGs with relevance to kidney health that require attention and reveal inter-linkages among the SDGs that should accelerate progress.


Assuntos
Acessibilidade aos Serviços de Saúde , Nefropatias/prevenção & controle , Nefropatias/terapia , Nefrologia , Terapia de Substituição Renal , Desenvolvimento Sustentável , Doença Catastrófica/economia , Diagnóstico Precoce , Intervenção Médica Precoce , Educação , Equidade de Gênero , Gastos em Saúde , Humanos , Nefropatias/economia , Pobreza , Comportamento de Redução do Risco , Determinantes Sociais da Saúde , Assistência de Saúde Universal , Violência
6.
Clin J Am Soc Nephrol ; 16(1): 79-87, 2020 12 31.
Artigo em Inglês | MEDLINE | ID: mdl-33323461

RESUMO

BACKGROUND AND OBJECTIVES: People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management. RESULTS: Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery. CONCLUSIONS: Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.


Assuntos
Tratamento Conservador , Países Desenvolvidos/estatística & dados numéricos , Países em Desenvolvimento/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Falência Renal Crônica/terapia , Qualidade da Assistência à Saúde , Tratamento Conservador/normas , Tomada de Decisão Compartilhada , Humanos , Internacionalidade , Equipe de Assistência ao Paciente/estatística & dados numéricos , Religião , Apoio Social , Inquéritos e Questionários
8.
Kidney Int Suppl (2011) ; 8(2): 41-51, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30675438

RESUMO

Reliable governance and health financing are critical to the abilities of health systems in different countries to sustainably meet the health needs of their peoples, including those with kidney disease. A comprehensive understanding of existing systems and infrastructure is therefore necessary to globally identify gaps in kidney care and prioritize areas for improvement. This multinational, cross-sectional survey, conducted by the ISN as part of the Global Kidney Health Atlas, examined the oversight, financing, and perceived quality of infrastructure for kidney care across the world. Overall, 125 countries, comprising 93% of the world's population, responded to the entire survey, with 122 countries responding to questions pertaining to this domain. National oversight of kidney care was most common in high-income countries while individual hospital oversight was most common in low-income countries. Parts of Africa and the Middle East appeared to have no organized oversight system. The proportion of countries in which health care system coverage for people with kidney disease was publicly funded and free varied for AKI (56%), nondialysis chronic kidney disease (40%), dialysis (63%), and kidney transplantation (57%), but was much less common in lower income countries, particularly Africa and Southeast Asia, which relied more heavily on private funding with out-of-pocket expenses for patients. Early detection and management of kidney disease were least likely to be covered by funding models. The perceived quality of health infrastructure supporting AKI and chronic kidney disease care was rated poor to extremely poor in none of the high-income countries but was rated poor to extremely poor in over 40% of low-income countries, particularly Africa. This study demonstrated significant gaps in oversight, funding, and infrastructure supporting health services caring for patients with kidney disease, especially in low- and middle-income countries.

9.
Kidney Int Suppl ; (98): S30-6, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16108968

RESUMO

Latin America (LA), defined here as the countries in the Western hemisphere located south of the United States, is a region with a total population of nearly 520,000,000 that increases 1.5% annually and has a human development index of 0.77. The countries that form this region present extreme contrasts. These contrasts are first and foremost within the countries themselves, because extremes of wealth and poverty are present in their social and economic fabric. In addition, in LA a vast variety of government modalities and political systems are represented. Therefore, in order for prevention strategies to be effective, they need to be tailored to the specific characteristics and idiosyncrasies of individual nations. This article will address the following aspects: first, a broad outline of the basic health statistics in LA, with focus on treatment of end-stage renal disease and its derived economic burden. Data from LA countries will be contrasted with 95% confidence interval of corresponding data from 10 industrialized countries (Canada, France, Germany, Italy, Japan, United Kingdom, United States, Spain, Sweden, and Switzerland). Second, we will discuss the prevalence of some risk factors for end-stage renal disease in the nations of the region. For this reason, we will focus on data that provide reliable information. Finally, we will consider general guidelines for the implementation of prevention strategies that may have common applicability in LA countries.


Assuntos
Falência Renal Crônica/prevenção & controle , Complicações do Diabetes/epidemiologia , Mão de Obra em Saúde/estatística & dados numéricos , Humanos , Hipertensão/complicações , Recém-Nascido de Baixo Peso , Recém-Nascido , Falência Renal Crônica/economia , América Latina/epidemiologia , Diálise Renal/economia , Fatores de Risco
10.
Kidney Int Suppl ; (97): S18-22, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16014094

RESUMO

Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela. Numerous studies have documented the presence of racial and minority disparities regarding the impact of renal disease and access to renal replacement therapy (RRT). This problem is less well documented in Latin America. Venezuela, like most countries in the region, is subject to severe constraints in the allocation of resources for high-cost chronic diseases, which limits the access of patients with chronic kidney disease to RRT. Although access to health care is universal, there is both a deficit in coverage and disparity in the access to RRT, largely as a result of socioeconomic limitations and budget constrains. With current rising trends of the incidence of end-stage renal disease (ESRD) and costs of medical technology, the long-term goal of complete RRT coverage will become increasingly out of reach. Current evidence suggests that prevention of progression of renal disease is possible at relatively low cost and broad coverage. Based on this evidence, the Ministry of Health has redesigned its policy with respect to renal disease based on 4 elements: 1. Prevention by means of early detection and referral to multidisciplinary health teams, as well as promotion of health habits in the community. 2. Prevention of progression of renal disease by pharmacologic and nonpharmacologic means. 3. An increase in the rate of coverage and reduction of disparities in the access to dialysis. 4. An increase in the rates of renal transplantation through better organ procurement programs and reinforcement of transplant centers. However, the projected increase in the number of patients with ESKD receiving RRT will represent a serious burden to the health care system. Therefore, implementation of these policies will require the involvement of international agencies as well as an adequate partnership between nephrologists and health care planners, so that meeting the increasing demands of ESKD programs may be balanced with other priorities of our national health system.


Assuntos
Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Falência Renal Crônica/terapia , Transplante de Rim/estatística & dados numéricos , Diálise Renal/estatística & dados numéricos , Etnicidade , Política de Saúde , Humanos , Falência Renal Crônica/epidemiologia , Falência Renal Crônica/cirurgia , Grupos Minoritários , Venezuela/epidemiologia
11.
Artif Organs ; 26(9): 747-9, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12197925

RESUMO

In Venezuela there are 3234 new cases (132 per million population [pmp]) requiring renal replacement therapy each year, and only 40% of these are admitted to the different modalities of dialysis. In the year 2000, there were 195 patients pmp in chronic hemodialysis (4700 patients). Diabetes, glomerular diseases, and hypertension account for more than 60% of the patients in chronic dialysis. Gross mortality in hemodialysis is around 20%, and cardiovascular causes are the primary cause of death (39.5%). Hospital admission in the dialysis patients amounts to 4.6 days/patient/year. Rehabilitation is inadequate. Only 45% of the dialysis patients report normal home or work activities. Transplantation in Venezuela has a general graft survival rate of 83% at 1 year (90% for living related grafts) and 50% (64% for living related grafts) at 10 years. Future tendencies include emphasis in preventive strategies, including early detection and treatment of diabetes and hypertension, as well as efforts to increase the rate of renal transplantation.


Assuntos
Falência Renal Crônica/epidemiologia , Adulto , Países em Desenvolvimento , Previsões , Política de Saúde/tendências , Humanos , Falência Renal Crônica/etiologia , Falência Renal Crônica/mortalidade , Falência Renal Crônica/terapia , Pessoa de Meia-Idade , Fatores Socioeconômicos , Venezuela/epidemiologia
12.
Invest. clín ; 34(1): 15-27, 1993. tab
Artigo em Espanhol | LILACS | ID: lil-133128

RESUMO

El número de donantes de órganos disponibles para trasplante en la actualidad es insuficiente. A pesar de múltiples esfuerzos realizados, no se ha logrado hasta la fecha mejorar esa deficiencia. Esto ha determinado un incremento progresivo de la lista de espera de órganos para trasplante. El objetivo principal de este trabajo es cuantificar la necesidad de riñones para trasplante, así como la oferta de los mismos en relación a la demanda en Venezuela. Se presenta un resumen de la actividad de trasplante renal en el país, apreciándose que a partir de 1993 hay un predominio de los trasplantes con donante cadavérico, sin llegar a un nivel óptimo. La actividad anual de trasplante se estabilizó entre 1989 y 1991 en 6 trasplantes /millón de habitantes, decreciendo dicha tasa a 4,3 en 1992. El cálculo del número de donantes necesario para cubrir la demanda real existente corresponde a 10 donantes/millón de habitantes. Esto contrasta con la tasa de donación de solo 2.01 y 1.92 donantes/millón alcanzada en 1990 y 1991 respectivamente. La causa más frecuente de no donación fue la ausencia de autorización familiar. Basados en el análisis de los factores que inciden en la escasez de órganos para trasplante se presentan algunas recomendaciones para aumentar la disponibilidad de donantes de órganos en el país. Estas medidas incluyen mejorar algunos aspectos educativos y legales en el campo de la donación de órganos e iniciar un programa de coordinadores hospitalarios de trasplante, siguiendo el modelo español, que puedan detectar y evaluar los donantes potenciales así como coordinar los aspectos logísticos del trasplante


Assuntos
Humanos , Necessidades e Demandas de Serviços de Saúde , Transplante de Rim , Doadores de Tecidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA